Page 27 - JCTR-11-2
P. 27

Journal of Clinical and
            Translational Research                                                        US-mediated drug delivery



            7.   Mizee MR, Nijland PG, van der Pol SMA, et al. Astrocyte-     doi: 10.1093/neuonc/noae087
               derived retinoic acid: A  novel regulator of blood-brain   18.  Zhang Y, Liu Q, Zhang X,  et al. Recent advances in
               barrier function in multiple sclerosis.  Acta Neuropathol.   exosome-mediated nucleic acid delivery for cancer therapy.
               2014;128(5):691-703.
                                                                  J Nanobiotechnology. 2022;20(1):279.
               doi: 10.1007/s00401-014-1335-6                     doi: 10.1186/s12951-022-01472-z
            8.   Korczyn AD. Vascular parkinsonism--characteristics,   19.  Bouakaz A, Michel Escoffre J. From concept to early
               pathogenesis  and  treatment.  Nat  Rev  Neurol.   clinical trials: 30  years of microbubble-based ultrasound-
               2015;11(6):319-326.                                mediated drug delivery research.  Adv Drug Deliv Rev.
               doi: 10.1038/nrneurol.2015.61                      2024;206:115199.
            9.   Drouin-Ouellet J, Sawiak SJ, Cisbani G, et al. Cerebrovascular      doi: 10.1016/j.addr.2024.115199
               and blood-brain barrier impairments in Huntington’s   20.  Hynynen K. Focused ultrasound for blood-brain disruption
               disease: Potential implications for its pathophysiology. Ann   and delivery of therapeutic molecules into the brain. Expert
               Neurol. 2015;78(2):160-177.                        Opin Drug Deliv. 2007;4(1):27-35.
               doi: 10.1002/ana.24406                             doi: 10.1517/17425247.4.1.27
            10.  Wijesuriya HC, Bullock JY, Faull RLM, Hladky SB,   21.  Konofagou EE, Tung YS, Choi J, Deffieux T, Baseri B,
               Barrand MA. ABC efflux transporters in brain vasculature   Vlachos  F. Ultrasound-induced blood-brain barrier
               of Alzheimer’s subjects. Brain Res. 2010;1358:228-238.  opening. Curr Pharm Biotechnol. 2012;13(7):1332-1345.
               doi: 10.1016/j.brainres.2010.08.034                doi: 10.2174/138920112800624364
            11.  Palmer  AM.  The  role  of the  blood-CNS  barrier  in   22.  Hynynen  K, McDannold  N, Vykhodtseva  N,  et al. Focal
               CNS disorders and their treatment.  Neurobiol Dis.   disruption of  the blood-brain barrier due to 260-kHz
               2010;37(1):3-12.                                   ultrasound bursts: A  method for molecular imaging and
               doi: 10.1016/j.nbd.2009.07.029                     targeted drug delivery. J Neurosurg. 2006;105(3):445-454.
            12.  Alarcan H, Al Ojaimi Y, Lanznaster D,  et al. Taking      doi: 10.3171/jns.2006.105.3.445
               advantages of blood-brain or spinal cord barrier alterations   23.  Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE.
               or restoring them to optimize therapy in ALS? J Pers Med.   Noninvasive, transient and selective blood-brain barrier
               2022;12(7):1071.                                   opening  in non-human primates  in vivo.  PLoS One.
               doi: 10.3390/jpm12071071                           2011;6(7):e22598.
            13.  Pardridge WM, Boado RJ. Reengineering biopharmaceuticals      doi: 10.1371/journal.pone.0022598
               for targeted delivery across the blood-brain barrier. Methods   24.  McDannold  N,  Arvanitis  CD,  Vykhodtseva  N,
               Enzymol. 2012;503:269-292.                         Livingstone MS. Temporary disruption of the blood-brain
               doi: 10.1016/B978-0-12-396962-0.00011-2            barrier by use of ultrasound and microbubbles: Safety
                                                                  and efficacy evaluation in rhesus macaques.  Cancer Res.
            14.  Chacko AM, Li C, Pryma DA, Brem S, Coukos G,     2012;72(14):3652-3663.
               Muzykantov V. Targeted delivery of antibody-based
               therapeutic and imaging agents to CNS tumors: Crossing      doi: 10.1158/0008-5472.CAN-12-0128
               the blood-brain barrier divide.  Expert Opin Drug Deliv.   25.  Rapoport N. Drug-loaded perfluorocarbon nanodroplets
               2013;10(7):907-926.                                for ultrasound-mediated drug delivery. Adv Exp Med Biol.
               doi: 10.1517/17425247.2013.808184                  2016;880:221-241.
            15.  Han L. Modulation of the blood-brain barrier for drug      doi: 10.1007/978-3-319-22536-4_13
               delivery to brain. Pharmaceutics. 2021;13(12):2024.  26.  Hynynen K, McDannold N,  Vykhodtseva N, Jolesz  FA.
               doi: 10.3390/pharmaceutics13122024                 Noninvasive MR imaging-guided focal opening of the blood-
                                                                  brain barrier in rabbits. Radiology. 2001;220(3):640-646.
            16.  Al Ojaimi Y, Blin T, Lamamy J,  et al. Therapeutic
               antibodies - natural and pathological barriers and strategies      doi: 10.1148/radiol.2202001804
               to overcome them. Pharmacol Ther. 2022;233:108022.  27.  Hynynen K, McDannold N,  Vykhodtseva N, Jolesz  FA.
               doi: 10.1016/j.pharmthera.2021.108022              Non-invasive opening of BBB by focused ultrasound. Acta
                                                                  Neurochir Suppl. 2003;86:555-558.
            17.  Piper K, Kumar JI, Domino J, Tuchek C, Vogelbaum MA.
               Consensus review on strategies to improve delivery across      doi: 10.1007/978-3-7091-0651-8_113
               the blood-brain barrier including focused ultrasound. Neuro   28.  Ibsen S, Schutt CE, Esener S. Microbubble-mediated
               Oncol. 2024;26(9):1545-1556.                       ultrasound therapy: A  review of its potential in cancer


            Volume 11 Issue 2 (2025)                        21                            doi: 10.36922/jctr.24.00061
   22   23   24   25   26   27   28   29   30   31   32